Patent EP0414035A2 successfully refreshed from Google Patents.
EP0414035A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Gibbon ape leukemia virus receptor
Assignee: Wyeth Holdings LLC
•
Filing: 1990-08-14
•
Granted: —
•
Expires: 2010-08-14
Abstract
Abstract The present invention relates to the gibbon ape leukemia virus (GALV) receptor protein and the methods for regulating viral entry into cells.
Inventors
- 👤 Bryan Mark O'hara
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-04 15:31
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C07; C07K; C07K14/00; C07K14/435; C07K14/705; A; A61; A61P; A61P31/00; A61P31/12
Claims Analysis
Total Claims: 21
Claim 1
Independent Claim
3 words
GALV receptor protein.
Claim 2
Dependent Claim
3 words
GALV receptor protein.
Claim 3
Dependent Claim
35 words
GALV receptor protein having the amino acid sequence defined in Figure 7 or having substantially the same amino acid sequence and substantially the same capacity to allow viral infection as the protein in Figure 7.
Claim 4
Dependent Claim
35 words
GALV receptor protein having the amino acid sequence defined in Figure 7 or having substantially the same amino acid sequence and substantially the same capacity to allow viral infection as the protein in Figure 7.
Claim 5
Dependent Claim
4 words
Human GALV receptor protein.
Claim 6
Dependent Claim
4 words
Human GALV receptor protein.
Claim 7
Dependent Claim
19 words
The GALV receptor protein according to Claim 3, wherein said protein is derived from a species other than human.
Claim 8
Dependent Claim
12 words
GALV receptor protein having the amino acid sequence defined in Figure 7.
Claim 9
Dependent Claim
12 words
GALV receptor protein having the amino acid sequence defined in Figure 7.
Claim 10
Dependent Claim
10 words
A purified isolated DNA sequence encoding for GALV receptor protein.
Claim 11
Dependent Claim
10 words
A purified isolated DNA sequence encoding for GALV receptor protein.
Claim 12
Dependent Claim
35 words
The purified isolated DNA sequence encoding for GALV receptor protein defined in Figure 6 or having substantially the same DNA sequence and substantially the same amino acid coding sequence as the DNA in Figure 6.
Claim 13
Dependent Claim
35 words
The purified isolated DNA sequence encoding for GALV receptor protein defined in Figure 6 or having substantially the same DNA sequence and substantially the same amino acid coding sequence as the DNA in Figure 6.
Claim 14
Dependent Claim
18 words
The purified isolated DNA sequence according to Claim 6, wherein said GALV receptor protein is derived from human.
Claim 15
Dependent Claim
22 words
The purified isolated DNA sequence according to Claim 6, wherein said GALV receptor protein is derived from a species other than human.
Claim 16
Independent Claim
44 words
A method for identifying GALV receptor protein, said method comprising: selecting a DNA probe as identified in Figure 6 or a DNA sequence having substantially the same DNA sequence as that defined in Figure 6; isolating resulting DNA encoding the protein receptor for GALV.
Claim 17
Independent Claim
44 words
A method for identifying GALV receptor protein, said method comprising: selecting a DNA probe as identified in Figure 6 or a DNA sequence having substantially the same DNA sequence as that defined in Figure 6; isolating resulting DNA encoding the protein receptor for GALV.
Claim 18
Independent Claim
27 words
A method to regulate viral entry into cells, said method comprising: administering a gibbon-ape leukemia virus (GALV)-receptor protein regulating amount of a GALV-receptor protein-infecting-agent to said cells.
Claim 19
Independent Claim
27 words
A method to regulate viral entry into cells, said method comprising: administering a gibbon-ape leukemia virus (GALV)-receptor protein regulating amount of a GALV-receptor protein-infecting-agent to said cells.
Claim 20
Dependent Claim
14 words
A method according to Claim 11, wherein said GALV-affecting agent is administered to animals.
Claim 21
Dependent Claim
15 words
A method according to Claim 12, wherein said GALV-affecting agent is administered to warm-blooded animals.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.